Get startedLog in
    Picture of Chosa Oncology AB logo

    CHOSA — Chosa Oncology AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Canadian Intellectual Property Office Intends To Grant Rhovac's Patent Application For Rv001 (Onilcamotide) Cancer Vaccine

    Picture of Chosa Oncology AB logoChosa Oncology AB
    24/01/2022 12:58
    Jan 24 (Reuters) - RhoVac AB  RHOVAC.TE :
    * CANADIAN INTELLECTUAL PROPERTY OFFICE INTENDS TO GRANT
RHOVAC'S
PATENT APPLICATION FOR RV001 (ONILCAMOTIDE) CANCER VACCINE

Source text for Eikon:  ID:nPreqmM1Sa 
Further company coverage:  RHOVAC.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Chosa Oncology AB

    See all news